作者更正：犬乳腺癌中三阴性导管原位癌（DCIS）进展至浸润阶段的DNA甲基化图谱
Author Correction: DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer.
作者信息
Beetch Megan, Harandi-Zadeh Sadaf, Yang Tony, Boycott Cayla, Chen Yihang, Stefanska Barbara, Mohammed Sulma I
机构信息
Food, Nutrition & Health Program, Faculty of Land and Food Systems, University of British Columbia, Vancouver, Canada.
Department of Comparative Pathobiology, Purdue University, West Lafayette, IN, USA.
出版信息
Sci Rep. 2020 Mar 19;10(1):5370. doi: 10.1038/s41598-020-62220-7.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
摘要
本文的一个修订版本已发表，可通过本文顶部的链接获取。
相似文献
1
Author Correction: DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer.
Sci Rep. 2020 Mar 19;10(1):5370. doi: 10.1038/s41598-020-62220-7.
2
Author Correction: Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature.
Sci Rep. 2020 Mar 6;10(1):4468. doi: 10.1038/s41598-020-61260-3.
3
DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.
Clin Epigenetics. 2015 Jul 25;7(1):75. doi: 10.1186/s13148-015-0094-0. eCollection 2015.
4
Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis.
Breast Cancer Res Treat. 2015 Aug;153(1):101-21. doi: 10.1007/s10549-015-3509-x. Epub 2015 Aug 9.
5
Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
J Pathol. 2011 Oct;225(2):222-31. doi: 10.1002/path.2930. Epub 2011 Jun 27.
6
Author Correction: Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients.
Sci Rep. 2019 Dec 5;9(1):18700. doi: 10.1038/s41598-019-44070-0.
7
Promoter hypermethylation in ductal carcinoma in situ of the male breast.
Endocr Relat Cancer. 2019 Jun;26(6):575-584. doi: 10.1530/ERC-18-0485.
8
"Development and validation of algorithms to differentiate ductal carcinoma in situ from invasive breast cancer within administrative claims data" by Hirth JM, Hatch SS, Lin Y, Giordano SH, Silva HC, Kuo Y.
Cancer. 2019 Apr 1;125(7):1200. doi: 10.1002/cncr.31886. Epub 2019 Jan 16.
9
Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.
Oncotarget. 2015 Apr 10;6(10):7597-607. doi: 10.18632/oncotarget.3162.
10
Author Correction: Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with Cisplatin in triple-negative breast cancer cells.
Sci Rep. 2019 Dec 10;9(1):19124. doi: 10.1038/s41598-019-55880-7.
Zotero 插件